Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 10 Projects
Project # Contact PI Funding Organization Fiscal Year
A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform
ADDF-13 Ballard, Clive Alzheimer's Drug Discovery Foundation 2020
Evaluating the effects of the novel GLP-I analogue, liraglutide, in patients with Alzherimer's disease (ELAD Study) - Open Label Extension
GC-2013910 Edison, Paul Alzheimer's Drug Discovery Foundation 2017
Novel Point-of-Care Diagnostic Techniques for Dementia
EUJPND-EPSRC-Ifeachor-2235 Ifeachor, E UK Engineering and Physical Sciences Research Council (EPSRC) 2016
"EPSRC - NIHR HTC Partnership Award: Partnership with the MindTech HTC
EUJPND-EPSRC-Taylor-2247 Taylor, CJ UK Engineering and Physical Sciences Research Council (EPSRC) 2016
Etanercept in Alzheimer's Disease: a randomised, placebo controlled, double-blind phase 2 trial
GH-2012563 HOLMES, CLIVE Alzheimer's Drug Discovery Foundation 2015
Repurposing the PDE5 inhibitor tadalafil for vascular cognitive impairment. A test of concept in older people
20140901-Hainsworth-2014 Hainsworth, Atticus Alzheimer's Drug Discovery Foundation 2014
Novel GLP-1 and GIP dual receptor agonist peptides show neuroprotective effects
222-Holscher-2014 Holscher, Christian Alzheimer's Drug Discovery Foundation 2014
Repurposed drugs targeting the unfolded protein response to prevent neurodegeneration in dementia
223-Mallucci-2014 Mallucci, Giovanna Alzheimer's Drug Discovery Foundation 2014
Effect of Novel GLP1 analogue, Liraglutide on microglial activation and cerebral glucose metabolism in mild Alzheimer's disease.
20111202-Edison-2011 Edison, Paul Alzheimer's Drug Discovery Foundation 2011
Characterization in vivo of a newly identified peptide of potential pivotal significance to Alzheimer's disease
290203-Greenfield-2009 Greenfield, Susan Alzheimer's Drug Discovery Foundation 2009